CLINICAL OUTCOMES OF TEGOPRAZAN OR PPI COMBINATION THERAPY IN PATIENTS TAKING ANTIPLATELET AGENTS AFTER PERCUTANEOUS CORONARY INTERVENTION

被引：0

|

作者：

Lee, Jin

Park, Jongha

Park, Jino

Na, Ji Eun

Park, Yong Eun

Choi, Joon Hyuk

Kim, Tae Oh

机构：

来源：

GASTROENTEROLOGY | 2024年 / 166卷 / 05期

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

Tu1360

引用

收藏

页码：S1313 / S1314

页数：2

相关论文

共 50 条

[31] Triple antiplatelet therapy improves short-term outcomes after percutaneous coronary intervention
Han, Yaling
Li, Yi
Shu, Qingfen
Wang, Shouli
Jing, Quanmin
Wang, Dongmei
Wang, Zulu
AMERICAN JOURNAL OF CARDIOLOGY, 2006, 98 (8A): : 202M - 202M
[32] Antithrombotic and Antiplatelet Therapy in Patients Requiring Oral Anticoagulation After Percutaneous Coronary Intervention
Ayoub, Karam
Marji, Meera
Nairooz, Ramez
AMERICAN JOURNAL OF CARDIOLOGY, 2015, 116 (05): : 828 - 829
[33] Clinical Outcomes of Prolonged Antiplatelet Therapy after Percutaneous Coronary Intervention in Chronic Kidney Disease Patients: A Systematic Review and Meta-Analysis
Zhang, Jialing
Li, Han
Wang, Shixiang
BLOOD PURIFICATION, 2023, 52 (03) : 255 - 263
[34] Considerations in patients receiving oral antiplatelet therapy after acute coronary syndrome and percutaneous coronary intervention
Roffman, David S.
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2010, 67 (15) : S18 - S24
[35] Exclusive Antiplatelet Therapy for Percutaneous Coronary Intervention
Denardo, Scott J.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2009, 53 (20) : 1921 - 1922
[36] Dual antiplatelet therapy after percutaneous coronary intervention: Personalize the duration
Howard, Travis M.
Khot, Umesh N.
CLEVELAND CLINIC JOURNAL OF MEDICINE, 2021, 88 (06) : 325 - 332
[37] EFFICACY OF RECTAL DUAL ANTIPLATELET THERAPY AFTER PERCUTANEOUS CORONARY INTERVENTION
Nowrozi, Arian
Kim, Michael
Gavrilos, George
Hadley, Sydney
Kabbany, Mohammad
CRITICAL CARE MEDICINE, 2024, 52
[38] Oral antiplatelet therapy and percutaneous coronary intervention
Yan, BPY
Clark, DJ
Ajani, AE
EXPERT OPINION ON PHARMACOTHERAPY, 2005, 6 (01) : 3 - 12
[39] The Role of Novel Oral Anticoagulants and Antiplatelet Therapy after Percutaneous Coronary Intervention: Individualizing Therapy to Optimize Outcomes
Shlofmitz, Evan
Shlofmitz, Richard
Lee, Michael S.
KOREAN CIRCULATION JOURNAL, 2019, 49 (08) : 645 - 656
[40] PREDICTABLE DELIVERY OF ANTIPLATELET AGENTS AFTER STENT PLACEMENT IN PERCUTANEOUS CORONARY INTERVENTION
Ifedili, I.
Puperi, D.
Ibebuogu, U. N.
JOURNAL OF INVESTIGATIVE MEDICINE, 2019, 67 (02) : 387 - 387

← 1 2 3 4 5 →